My son has a terminal disease — why FDA delays are failing families like mine
Opinion
My son has a terminal disease — why FDA delays are failing families like mine
The departure of FDA biologics director Vinay Prasad creates an opportunity for a reset
By Angelina Olivera Fox News
Published April 29, 2026 5:00am EDT
Facebook Twitter Threads Flipboard Comments Print Email Add Fox News on Google
close
Video
Dr. Marty Makary on estrogen patch shortages and FDA's role
FDA Commissioner Dr. Marty Makary discusses the demand surge and shortages of estrogen patches. He explains the FDA's decision to remove the black box warning, leading to increased demand, and its impact on women's health and menopause.
NEWYou can now listen to Fox News articles!
I’ve spent over 40 years on the front line against a terminal illness that killed my brothers and put my 14-year-old son into a wheelchair. This week, I asked Food & Drug Administration (FDA) Commissioner Dr. Martin Makary to leave his gilded office and come visit my home, because I fear that he’s lost touch with terminally ill children like Ryu.
I’m Ryu’s full-time caretaker. Like most rare disease families, we rely on one income and have limited financial resources. What we do have are astronomical medical expenses; Ryu’s steroids alone are $30,000 per month. My husband and I thankfully found a nonprofit that covered the remaining $2,000 after our insurance paid their portion — but other expenses fall squarely on us.
It’s easy to ignore these struggles when you’re a powerful official in Washington, D.C. In my house, Ryu struggles to breathe because of Duchenne muscular dystrophy, the same........
